Drugs / TVR
last change May 2012 re-read 2 minutes ago

TVR

Investigated by
GlaxoSmithKline · Shionogi · ViiV Healthcare

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01563328 Mar → May 2012 HIV infectious disease ViiV Healthcare Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TVR ClinicalTrials.gov intervention name — accepted as the source's own label NCT01563328
Action Inhibit “Boceprevir (BCV) and Telaprevir (TVR) are protease inhibitors” NCT01563328